`USDC-SDNY
`
`UNITED STATES DISTRICT COURT
`SOUTHERN DISTRICT OF NEW YORK
`
`NETSOC, LLC,
`
`DOCUMENT
`
`ELECTRONICALLY FILED
`
`DOC#:
`DATE FILED:
`
`/ / 13/ Z ~ Lo
`
`V.
`
`V.
`
`V.
`
`CHEGGINC.,
`
`NETSOC, LLC,
`
`LINKEDIN CORP.,
`
`NETSOC, LLC,
`
`OATH INC.,
`
`Plaintiff,
`
`MEMORANDUM OPINION & ORDER
`
`No. 18-CV-10262 (RA)
`
`Defendant.
`
`Plaintiff,
`
`Defendant.
`
`Plaintiff,
`
`Defendant.
`
`No. 18-CV-12215 (RA)
`
`No. 18-CV-12267 (RA)
`
`RONNIE ABRAMS, United States District Judge:
`
`On November 5, 2018, PlaintiffNetSoc, LLC brought this patent infringement action
`
`against Defendant Chegg Inc. Plaintiff owns U.S. Patent 9,978,107 (the "' 107 Patent"),
`
`described generally as "a method and system for establishing and using a social network to
`
`
`
`Case 1:18-cv-12267-RA Document 90 Filed 01/13/20 Page 2 of 5
`
`facilitate people in life issues," by assignment. Dkt. 1, Compl. Jr 8. 1 It asserts that "Chegg
`
`maintains, operates, and administers a website at www.chegg.com that infringes one or more
`
`claims of the '107 patent." Id. Jr 9. On February 19, 2019, Chegg filed a motion to dismiss,
`
`pursuant to Federal Rule of Civil Procedure 12(b)(6), based on several grounds, including that
`
`"the asserted patent ... fails to claim patent-eligible subject matter under 35 U.S.C. § 101." Dkt.
`
`25. On September 10, 2019, following a decision in the Northern District of Texas finding the
`
`'107 Patent invalid under 35 U.S.C. § 101, Chegg filed a supplemental brief arguing that
`
`Plaintiff is collaterally estopped from pursuing its patent infringement claims against Chegg. See
`
`Dkt. 88. Plaintiff acknowledges as much and the Court agrees. Plaintiffs claims against Chegg
`
`must thus be dismissed.
`
`"Issue preclusion," or collateral estoppel, "prohibits a party from seeking another
`
`determination of the litigated issue in [a] subsequent action." Soverain Software LLC v.
`
`Victoria's Secret Direct Brand Mgmt., LLC, 778 F .3d 1311, 1315 (Fed. Cir. 2015). "The
`
`purpose of the doctrine is to relieve parties of the cost and vexation of multiple lawsuits,
`
`conserve judicial resources, and, by preventing inconsistent decisions, encourage reliance on
`
`adjudication." Medino! Ltd v. Guidant Corp., 341 F. Supp. 2d 301,314 (S.D.N.Y. 2004)
`
`(citation omitted). "Four elements must be met for collateral estoppel to apply: (1) the issues of
`
`both proceedings must be identical, (2) the relevant issues were actually litigated and decided in
`
`the prior proceeding, (3) there must have been 'full and fair opportunity' for the litigation of the
`
`issues in the prior proceeding, and (4) the issues were necessary to support a valid and final
`
`judgment on the merits." Cent. Hudson Gas & Elec. Corp. v. Empresa Naviera Santa S.A., 56
`
`F.3d 359, 368 (2d Cir. 1995).
`
`1 Throughout the opinion, the Court cites submissions filed on the docket in NetSoc, LLC v. Chegg Inc.,
`No. 18-CV-10262.
`
`2
`
`
`
`Case 1:18-cv-12267-RA Document 90 Filed 01/13/20 Page 3 of 5
`
`In patent cases, "(i]t is well established that 'once the claims of a patent are held invalid
`
`in a suit involving one alleged infringer, an unrelated party who is sued for infringement of those
`
`claims may reap the benefit of the invalidity decision under the principles of collateral
`
`estoppel."' Purdue Pharma L.P. v. Teva Pharm. USA, Inc., Nos. 01-CV-8507 (SHS), 01-CV-
`
`11212 (SHS), 03-CV-2312 (SHS), 2004 WL 1444883, at *2 (S.D.N.Y. June 28, 2004) (quoting
`
`Pharmacia & Upjohn Co. v. Mylan Pharm., Inc., 170 F.3d 1373, 1379 (Fed. Cir. 1999)). "[T]he
`
`Federal Circuit has 'established that issue preclusion applies even though the precluding
`
`judgment ... comes into existence' after the initiation of 'the case as to which preclusion is
`
`sought." Control v. Dig. Playground, Inc., Nos. 12-CV-6781 (RJS), 12-CV-7734 (RJS), 2016
`
`WL 5793745, at *4 (S.D.N.Y. Sept. 30, 2016) (quoting Soverain Software LLC, 778 F.3d at
`
`1315)).
`
`This action against Chegg was just one of several filed by Plaintiff - both in and outside
`
`of this district - in 2018. In addition to this case, which was consolidated with three others filed
`
`in this district, see Dkt. 35, Plaintiff brought claims against Match Group, LLC in the Northern
`
`District of Texas. Like its allegations against Chegg, Plaintiff asserted that Match Group, LLC
`
`had infringed on the '107 Patent "by operating several different online platforms, including
`
`Tinder and OkCupid." NetSoc, LLC v. Match Grp., LLC., No. 18-CV-1809, 2019 WL 3304704,
`
`at* 1 (N.D. Tex. July 22, 2019). On July 22, 2019, the United States District Court of the
`
`Northern District of Texas concluded that "PlaintiffNetSoc, LLC's ... patent claims are directed
`
`to only ineligible subject matter under 35 U.S.C. § 101." Id It thus dismissed Plaintiffs claims
`
`with prejudice, explaining that Plaintiffs "claims are directed to only patent ineligible abstract
`
`ideas, and fail to articulate an inventive concept that transforms those ideas into patent eligible
`
`subject matter." Id at *3 (holding that Plaintiffs claims fail the two-step test articulated in Alice
`
`3
`
`
`
`Case 1:18-cv-12267-RA Document 90 Filed 01/13/20 Page 4 of 5
`
`Corp. Pty. Ltd. v. CLS Bank International, 573 U.S. 208 (2014), used to determine patent
`
`eligibility under 35 U.S.C. § 101). After this decision, the Court requested supplemental briefing
`
`as to "whether Plaintiffs claims against [Chegg] are barred by collateral estoppel" in this action.
`
`Dkt. 74.
`
`As an initial matter, Plaintiff does not dispute that its claims against Chegg are now
`
`collaterally estopped. See Dkt. 94 ("Plaintiff agrees that collateral estoppel applies to assertions
`
`'
`of infringement of the '107 patent[.]"); Dkt. 104 ("A finding of collateral estoppel in light of the
`
`Texas Decision is appropriate regardless of Plaintiffs pending appeal."). 2
`
`Nonetheless, the Court must itselfreview the matter and decide whether the doctrine's
`
`requisite elements are met. See Cent. Hudson Gas & Elec. Corp., 56 F.3d at 368. Here, all four
`
`criteria for collateral estoppel are clearly satisfied. This action and the one brought in the
`
`Northern District of Texas involve the same plaintiff, alleging infringement of the same '107
`
`Patent. In both cases, the defendants challenged the validity of the '107 Patent under 35 U.S.C. §
`
`101, arguing that the claims were directed to patent ineligible abstract ideas and lacked an
`
`"inventive concept" that could otherwise transform the claims into patent eligible subject matter.
`
`See Dkt. 25, at 11-14; Match Grp., LLC, 2019 WL 3304704, at *3. The Northern District of
`
`Texas clearly resolved this issue with the benefit of full briefing and a hearing on this matter.
`
`Notably, Plaintiff was represented by the same counsel in those proceedings as it is here.
`
`Accordingly, there is no doubt that the issue was fully litigated before the Northern District of
`
`2 Although it agreed that collateral estoppel applies, Plaintiff initially asked "the Court [to] delay
`deciding if collateral estoppel applies to the claims of the '107 patent until at least after the decision on
`the motion for a New Trial pending in the Northern District of Texas[.]" Dkt. 94. Since filing that brief
`on September 16, 2019, however, the Northern District of Texas denied Plaintiff's motion for a new trial.
`See Dkt. 102. The fact that the case is now on appeal to the Federal Circuit does not alter the collateral
`estoppel analysis. See Pharmacia & Up john Co., 170 F.3d at 1381 ("[T]he law is well settled that the
`pendency of an appeal has no effect on the finality or binding effect of a trial court's holding. That rule is
`applicable to holdings of patent invalidity as well." (internal citations omitted)).
`
`4
`
`
`
`Case 1:18-cv-12267-RA Document 90 Filed 01/13/20 Page 5 of 5
`
`Texas and that "the patentee had both fair opportunity and incentive to litigate the validity issue
`
`in the first litigation." DietGoal Innovations LLC v. Time, Inc., No. 13-CV-8381 (PAE), 2014
`
`WL 3892965, at *I (S.D.N.Y. Aug. 8, 2014) (quoting Sampson v. Ampex Corp., 478 F.2d 339,
`
`341 (2d Cir. 1973)). Finally, the Northern District of Texas's conclusion that Plaintiff's patent
`
`claims were invalid under 35 U.S.C. § 101 was the basis - and, therefore, a necessary part of
`
`the decision to dismiss Plaintiffs claims with prejudice. Chegg, therefore, "may reap the benefit
`
`of th[is] invalidity decision under the principles of collateral estoppel." Purdue Pharma L.P.,
`
`2004 WL 1444883, at *2.
`
`For these reasons, Plaintiffs claims against Chegg are collaterally estopped and must be
`
`dismissed. The Clerk of Court is respectfully directed to terminate the motion pending at docket
`
`entry 24 and close the case number 18-CV-10262 against Chegg.
`
`Dated:
`
`January 13, 2020
`New York, New York
`
`United States District Judge
`
`5
`
`



